Revised regulations governing Health Canada's medicinal marijuana program reduce the onus on physicians as gatekeepers, but the 4-year-old program is still cause for concern, says the CMA.
![Figure](https://www.cmaj.ca/content/cmaj/173/5/473.2/F1.medium.gif)
Figure. Canada's approach to medicinal marijuana is evolving. Photo by: PhytoCan Pharmaceuticals
Under the revised Marihuana Medical Access Regulations, which came into effect June 29, physicians no longer have to make a risk–benefit declaration or recommend daily dosages.
Instead, applicants must acknowledge that the benefits and risks are not “fully understood” and that they accept those risks. Applicants also recommend their own dosage and route of administration, which the physician notes in his or her declaration.
Physicians must also state which of 2 categories (down from 3) the patient falls under (end-of-life or debilitating symptom) and that conventional treatments are inappropriate or ineffective.
CMA's Chief Medical Officer says that while this is a “more acceptable” approach, the CMA is still “fundamentally opposed because of the lack of [scientific] evidence. Physicians should not be gatekeepers to an unproven product,” says Dr. Isra Levy.
“It's challenging,” says Valerie Lasher, manager of Health Canada's Marihuana Access Division. “We don't have the research we need to make this an approved drug.” The program is “evolving,” she says.
The revised regulations also allow for a pilot project involving pharmacists who will distribute government-grown marijuana. Currently, the legal means of obtaining marijuana: are to get a government permit to grow it yourself or assign a grower, or to access the government supply via home delivery or a physician's office. Lasher says only 1 or 2 Canadian physicians now distribute marijuana.
“We want to move the program to a primary care model which includes distribution through pharmacies,” says Lasher. The pilot is expected to be complete by 2007.
The regulations also make it “reasonably clear that it's okay for doctors to refuse to participate,” says Levy.
Such clarity is desirable given that at least 1 college has brokered a complaint. In 2002, a patient complained to the Ontario college when his physician refused to prescribe marijuana (Members' Dialogue, March/April 2002:19-20). The college decided the physician was justified. “The issue of what constitutes the appropriate use of marijuana for medical purposes is still somewhat unsettled,” wrote the committee, which advised physicians to “tread carefully.”